Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma

Journal of Gastroenterology

Volumn 45, Issue 5, 2010, Pages 560-566

  Lee, Seung Won ^a   Kim, Hong Joo ^a   Park, Jung Ho ^a   Park, Dong Il ^a   Cho, Yong Kyun ^a   Sohn, Chong Il ^a   Jeon, Woo Kyu ^a   Kim, Byung Ik ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Cholangiocarcinoma; Gallbladder cancer; Multidetector row CT; PET CT; Standardized uptake value

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BILE DUCT CARCINOMA; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST SENSITIVITY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISTANT METASTASIS; DRUG UPTAKE; FEMALE; GALLBLADDER CANCER; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; COHORT STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; GALLBLADDER NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77953322456     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-009-0188-6     Document Type: Article

References (21)

1. DR Farley AL Weaver DM Nagorney 1995 "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention Mayo Clin Proc 70 425 429 10.4065/70.5.425 1:STN:280:DyaK2M3kvVOlsw%3D%3D 7537346
2. JC Ruckert RI Ruckert K Gellert K Hecker JM Muller 1996 Surgery for carcinoma of the gallbladder Hepatogastroenterology 43 527 533 1:STN:280:DyaK28zpt1Kjsw%3D%3D 8799389
3. M Miyazaki H Ito K Nakagawa S Ambiru H Shimizu A Okuno, et al. 1999 Does aggressive surgical resection improve the outcome in advanced gallbladder carcinoma? Hepatogastroenterology 46 2128 2132 1:STN:280:DyaK1MvltFChug%3D%3D 10521954
4. K Chijiiwa M Tanaka 1994 Carcinoma of the gallbladder: an appraisal of surgical resection Surgery 115 751 756 1:STN:280:DyaK2c3lsFyrtQ%3D%3D 7910985
5. Y Fong W Jarnagin LH Blumgart 2000 Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention Ann Surg 232 557 569 10.1097/00000658- 200010000-00011 1:STN:280:DC%2BD3M%2Fhs1ehsg%3D%3D 10998654
6. Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BJ, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234:507-17; discussion 517-9.
7. Y Morimoto Y Tanaka T Ito M Nakahara H Nakaba T Nishida, et al. 2003 Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma J Hepatobiliary Pancreat Surg 10 432 440 10.1007/s00534-002-0842-3 14714164 (Pubitemid 38128793)
8. PC de Groen GJ Gores NF LaRusso LL Gunderson DM Nagorney 1999 Biliary tract cancers N Engl J Med 341 1368 1378 10.1056/NEJM199910283411807 10536130 (Pubitemid 29503577)
9. Park MS, Kim TK, Kim KW, Park SW, Lee JK, Kim JS, et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology. 2004;233:234-40.
10. JM Cha MH Kim SJ Jang 2007 Early bile duct cancer World J Gastroenterol 13 3409 3416 17659686
11. TF Hany HC Steinert GW Goerres A Buck GK von Schulthess 2002 PET diagnostic accuracy: improvement with in-line PET-CT system: initial results Radiology 225 575 581 10.1148/radiol.2252011568 12409597
12. D Lardinois W Weder TF Hany EM Kamel S Korom B Seifert, et al. 2003 Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 2500 2507 10.1056/NEJMoa022136 12815135 (Pubitemid 36706537)
13. M Selzner TF Hany P Wildbrett L McCormack Z Kadry PA Clavien 2004 Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 240 1027 1034 10.1097/01.sla.0000146145.69835.c5 15570208 discussion 1035-6 (Pubitemid 39602130)
14. S Heinrich GW Goerres M Schafer M Sagmeister P Bauerfeind BC Pestalozzi, et al. 2005 Positron emission tomography/computedtomography influences on the management of resectable pancreatic cancer and its cost-effectiveness Ann Surg 242 235 243 10.1097/01.sla.0000172095.97787.84 16041214 (Pubitemid 41033440)
15. Kim JY, Kim MH, Lee TY, Hwang CY, Kim JS, Yun SC, et al. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Am J Gastroenterol. 2008;103:1145-51.
16. G Antoch N Saoudi H Kuehl G Dahmen SP Mueller T Beyer, et al. 2004 Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-d-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET J Clin Oncol 22 4357 4368 10.1200/JCO.2004.08.120 15514377 (Pubitemid 41185156)
17. JH Lim 2003 Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings Am J Roentgenol 181 819 827
18. Greene FL, Page DL, Flemming ID, Fritz A, Balch CM, Haller DG, et al. AJCC cancer staging manual, 6th ed. New York: Springer; 2002.
19. H Petrowsky P Wildbrett DB Husarik TF Hany S Tam W Jochum, et al. 2006 Impact of integrated positron emission tomography on staging and management of gallbladder cancer and cholangiocarcinoma J Hepatol 45 43 50 10.1016/j.jhep.2006.03.009 16690156 (Pubitemid 43850623)
20. H Jadvar RW Henderson PD Conti 2007 [F-18] Fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma J Comput Assist Tomogr 31 223 228 10.1097/01.rct.0000237811.88251.d7 17414758 (Pubitemid 46573360)
21. T Kato E Tsukamoto Y Kuge C Katoh T Nambu A Nobuta, et al. 2002 Clinical role of 18F-FDG PET for initial staging of patients with extrahepatic bile duct cancer Eur J Nucl Med 29 1047 1054 10.1007/s00259-002-0852-z 1:CAS:528:DC%2BD38Xls12gu7Y%3D